TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
National Taiwan University reports research in tuberculosis
June 23rd, 2009
"Fluoroquinolones are frequently used to replace agents in first-line anti-tuberculosis (anti-TB) regimens in patients with TB who have drug-induced hepatic dysfunction. We investigated the safety of using fluoroquinolone in an area where TB is endemic and where there is a high incidence of drug-induced liver injury," researchers in Taipei, Taiwan report. "From September 2003 through August 2006, patients who had aspartate aminotransferase and/or alanine aminotransferase levels 13 times the upper limit of normal in the presence of hepatitis symptoms or who had aspartate aminotransferase and/or alanine aminotransferase levels 15 times the upper limit of normal after...
Source: TB & Outbreaks Week (2009-06-23)
|
